Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single oral dose study of ONO-2160/CD in healthy men and Parkinson's disease patients
jRCT2080222143Phase 1
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ONO-2160 in Parkinson's disease (PD) (2 arms), sponsored by Ono Pharmaceutical.
02
Drugs
ONO-2160
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080222143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222143.